Ganymed Pharmaceuticals AG;TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gGmbH
发明人:
Ugur Sahin,Ozlem Tureci,Rita Mitnacht-Kraus,Stefan Woll
申请号：
US15227565
公开号：
US10053512B2
申请日:
2016.08.03
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention relates to antibodies directed against an epitope located within the C-terminal portion of CLDN18.2 which are useful, for example, in diagnosing cancer and/or in determining whether cancer cells express CLDN18.2.
